Finance

June 29, 2026, marks the effective date for the 2026 Russell US Indexes reconstitution, one of the most significant trading events of the year. Asset managers are reconfiguring trillions of dollars in benchmarked products, leading to heightened liquidity and record volumes on the Nasdaq Closing Cross. Notable inclusions this year include Health In Tech joining the Russell Microcap Index and significant passive buying anticipated for SpaceX following its recent IPO activity.

Despite the broad market recovery, technology stocks recently experienced their worst five-day stretch of 2026 due to growing skepticism over the immediate returns of massive AI infrastructure investments. Investors have begun rotating capital out of mega-cap semiconductor names like Micron and into defensive sectors such as healthcare and utilities. This shift is highlighted by the outperformance of healthcare, which saw its strongest weekly gain in over four years as technology faltered.

The yield on the US 10-year Treasury note remained steady around 4.38% on Monday as the market anticipates Thursday's nonfarm payrolls report. Following recent comments from Federal Reserve officials and higher-than-expected inflation data, investors are closely monitoring labor strength for clues on future interest rate hikes. Major bond management firms have shifted focus toward the 5-year segment of the yield curve, seeking stability as expectations for a late-year rate cut remain uncertain.